{
    "Title": "A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model",
    "URL": "https://doi.org/10.1371/journal.pntd.0009969",
    "Published": "November 18, 2021",
    "Subject_Areas": [
        "Cholera",
        "Diarrhea",
        "Blood",
        "Blood plasma",
        "Vibrio cholerae",
        "Adverse events",
        "Gastrointestinal tract",
        "Drug therapy"
    ],
    "Authors": {
        "Rahsan Erdem": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Gwen Ambler": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Mohamed Al-Ibrahim": [
            "Pharmaron, Baltimore, Maryland, United States of America"
        ],
        "Katarzyna Fraczek": [
            "Pharmaron, Baltimore, Maryland, United States of America"
        ],
        "Steven D. Dong": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Christopher Gast": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Laina D. Mercer": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Michael Raine": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Sharon M. Tennant": [
            "Center for Vaccine Development and Global Health, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America"
        ],
        "Wilbur H. Chen": [
            "Center for Vaccine Development and Global Health, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America"
        ],
        "Eugenio L. de Hostos": [
            "PATH, Seattle, Washington, United States of America"
        ],
        "Robert K. M. Choy": [
            "PATH, Seattle, Washington, United States of America"
        ]
    }
}